
Pensioners do not need to panic over Revenue letter about owed tax
Revenue
is chasing tens of thousands of
pensioners
over owed tax,' the headline read in words that could cause some upset. But, for those who got letters from Revenue in recent weeks, the truth is nowhere near as alarming.
Yes, the
Revenue Commissioners
did send letters out to 68,000 people over the age of 65 about their 2022 tax affairs, but that was part of a larger exercise in which a total of nearly 270,000 'reminders' were sent to people as Revenue looks to close off files for the 2022 tax year, not a targeting of pensioners.
And, as Revenue has been keen to point out, the letters were reminders, not tax demands.
The tax officials are clearly treading careful after a furore over what it later admitted were insensitive letters were sent to around 115,000 pensioners back in 2012. It is not quite clear why there has been no such campaign in the intervening decade, but we are where we are.
READ MORE
However, if you have received one of these letters, it is quite likely that you could have some income tax owing for that year. And, indeed, for the years between then and now as well.
So, how has it happened and what do you need to do?
Sticking with pensioners, the reason people might find themselves with a tax bill is down to their sources of income.
The
Department of Social Protection
pays the State pension with no tax deductions as that income is comfortably below the threshold at which you would be liable for income tax.
The income tax threshold for a single or widowed person over the age of 65 is currently €18,000 – and double that, €36,000, for a couple. The maximum income under the State pension – including the Christmas bonus week - is €15,333.
But if you also have a private pension from your former workplace, it is almost certain that you will be liable for tax. Most people know this, to be fair, and pay the tax on the occupational pension – either at source through PAYE or by filing a return.
The issue is that they sometimes forget that once their income is over the exemption limit, all of that income is liable for tax – the untaxed State pension as well as the occupational pension.
Other income is also taxed. Most people are aware that any rental income they receive for a property they let out is taxable – once it is over the rent-a-room limit of €14,000 – but many might not return any income from share dividends, for instance, for tax.
Let's stick with the state pension for now. Back in 2022, this was paid at a maximum rate of €253.30 a week, or €13,424.90 for the year. If your overall income means it is liable for the standard 20 per cent rate of income tax, you will owe the Revenue €2,685.
The good news is that there will be no reckoning for
universal social charge (USC)
or
PRSI
. Neither is levied on social welfare payments regardless of overall income. In any case, people are no longer liable for PRSI on any income once they turn 66.
However, if your 'other income' is not a social welfare payment, USC might still be an issue. In 2022, it was levied at 0.5 per cent up to €12,012, at 2 per cent from there up to €21,295 and 4.5 per cent on anything over that – at least up to €70,044.
So what do you have to do now?
I would suggest that regardless of whether you do have tax due on your state pension or other income, you should file a return for 2022 now, if you have not already done so.
Given that Revenue believes tax may be due, it seems sensible to assume that the people in receipt of letters are already paying tax – either by filing a Form 12 tax return through Revenue's MyAccount online service or, through its ROS service for those filing Form 11 returns in relation to income from self-employment.
I'll assume those most discomfited by these letters are less sophisticated taxpayers so we will work through the MyAccount process.
First up, log in to your Revenue account using your PPS number, your date of birth and the password you created when the account was set up. Revenue will then send a single-use verification code to your phone. Input this and then go to PAYE Services, generally the first (blue) box on the page that opens when you log in.
Next, click on: 'Review your tax for the previous 4 years', then select 2022 from the drop down menu and click on 'Request' to get your preliminary end of year statement.
This should give you an assessment of what Revenue thinks you have received in income and have paid to date in tax, together with any tax it considers remains outstanding.
As the Department of Social Protection talks to Revenue, it should income your state pension income.
The next step is to complete an income tax return, especially if there are outstanding tax credits that you have not claimed – for things like medical expenses, mortgage interest, rent etc. These may go some way to mitigate any outstanding tax bill.
The online system takes you through the form step by step and there are guidance notes to help you on your way. Once you are happy it is completed, you submit it.
If you have previously submitted a return that needs to be amended in light of the Revenue letters, you can do so by selecting the year in question – 2022 in this case – and then clicking 'Amend' next to your annual return.
The main thing is not to get too worried about any outstanding liability, but also do not hide your head in the sand.
Revenue has said in its letters that even where there has been an underpayment, no money will be due immediately – although if you have it, you might wish to get it done and dusted immediately.
For those whose financial wriggle room in retirement is tight, Revenue says it will adjust any credits you are due going forward to retrieve any money owed.
Of course that will reduce your income so it is not a painless exercise. And, once you have 2022 out of the way, you can expect to have to go through a similar exercise for the subsequent years.
The bottom line is that no one should panic at receiving one of these letters, but you do need to engage with them. If money is owing, you are always better going to Revenue than to have them coming to you.
You can contact us at
OnTheMoney@irishtimes.com
with personal finance questions you would like to see us address.
If you missed last week's newsletter, you can read it
here
.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Irish Sun
2 hours ago
- The Irish Sun
British racing to go on strike for first time in its history in protest at betting tax rise with ALL meetings cancelled
Key figures within the sport are opposing a Government proposal RACE IS RUN British racing to go on strike for first time in its history in protest at betting tax rise with ALL meetings cancelled BRITISH racing is set to go on strike for the first time EVER next month. September 10 events at Carlisle, Uttoxeter, Kempton and Lingfield Park are all set to be scrapped. 1 Four events are set to be scrapped next month Credit: Getty The Treasury have proposed to up taxes paid by bookies on racig profits from 15 to 21 per cent. According to The Times, the British Horseracing Authority have organised the strike in opposition to the proposal. THIS IS A DEVELOPING STORY.. The Sun is your go to destination for the best football, boxing and MMA news, real-life stories, jaw-dropping pictures and must-see us on Facebook at and follow us from our main Twitter account at @TheSunFootball.


Irish Times
5 hours ago
- Irish Times
Gareth Sheridan: Nutriband ‘will help a lot of people who are dealing with addiction and people who are dealing with pain'
Nutriband is a pharmaceutical company that was founded in Dublin in 2012 before relocating to Florida in 2016. Gareth Sheridan, who recently announced his intention to run for president and has stepped aside for three months as chief executive, is its founder. The company's lead product is Aversa, which it describes as 'abuse-deterrent transdermal technology', which incorporates aversive agents to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential, specifically opioids. Its first application is its abuse-deterrent fentanyl transdermal patch, which it is developing to provide clinicians and patients with extended-release chronic pain relief. It is awaiting regulatory clearance for this product in the US. The company has operations in Florida, Georgia, and North Carolina, and recently began its expansion back to Dublin. READ MORE What lightbulb moment prompted you to start-up in business? It was originally a thesis idea. I had noticed a patch that my dad wears and began wondering what other types of medications could be delivered that way that had not been explored yet. The thesis became a business plan, and Nutriband was registered in 2012. Describe your business model and what makes your business unique. We structured the company in a unique way, using capital markets and a public listing approach. We listed on the OTC Markets in 2016 and started using stock to purchase companies and technologies in place of cash. This helped us to avoid raising expensive early capital and retain a major equity stake in the company today, even after an eventual qualification to list on the Nasdaq (in New York) in 2010. We also do not develop new drug applications. We take existing generic medications and use our technologies to improve upon those and relaunch them as a branded product again. What is your greatest business achievement to date? Growing the company to a level where we qualified to list on the Nasdaq Stock Exchange and getting to ring the opening bell. What was your back-to-the-wall moment and how did you overcome it? We almost got sued by the SEC (The US Securities and Exchange Commission) for an accidental erroneous disclosure in one of our filings while on the OTC markets. At first, we thought it could be explained. However, it grew to the point where they were doubling down. We hired an excellent attorney with SEC experience and eventually settled the issue in a cease-and-desist, no-admit, no-deny agreement. This led to our back-to-the-wall moment, where, while running on fumes financially, we received a rejection from Nasdaq in our first application. After a couple of days of self-pity, we got back to work, raised some working capital with existing shareholders, and grew the company's equity by $7.5 million (€6.4 million) over the course of the next year. We reapplied to list again successfully. What moment would you cite as a turning point for the company? Credibility provided by our Nasdaq listing and subsequent partnership with Kindeva Drug Delivery (formerly 3M Drug Delivery), where Kindeva supplied their generic approved fentanyl patch for us to add our technology to. What were the best and the worst pieces of advice you received when starting out? The worst advice was that banks and institutions have your company's best interests at heart. I firmly believe that today, Wall Street is built on companies failing, not succeeding. Describe your growth funding path. We were reluctant to raise expensive capital early on and instead listed the company to use stock as an acquisition currency to grow. Our gamble on this paid off, and although we raised modest cash along the way, we were able to build Nutriband without any significant seed or angel rounds. We reached a market capitalisation of $120 million (its market value currently is about $75 million), and we have been able to maintain stable and steady control as a result of the minimal capital rounds. We turn down anywhere from $5 million to $15 million on a weekly basis from funds and institutions because we do not need it. We are not in the business of raising money, and having as little dilution as possible is a core focus for us as a company. How will your market look in three years and where would you like your business to be? For our first product, we are expected to reach annual revenues of $200 million. Our second product is independently estimated to have upwards of $135 million in yearly revenue. We are targeting the billion dollar club before the end of 2027. What are your annual revenues and profits? We are not yet profitable, as is typical with clinical development-stage companies. However, we also contract manufacture sports tapes and products for brands such as Reebok and KT Tape. Our target revenue from this source for the financial year to the end of January 2026 is $3 million * . This goes towards operational costs and reduces our clinical burn. Why have you decided to seek a nomination for the presidency? It's never been a more important or relevant time in our history for a young president, particularly with the average age just under 40. I would be hoping that having a younger president would help narrow the division we're seeing in the country at the moment and that we can work together to tackle the issues, particularly the housing crisis. The younger generation aren't feeling very enthusiastic that their voices are being heard. What impact will this move have on your business? The company is in very safe hands and the biggest asset at the company is the team. We've got a very definite plan and timeline between now and Christmas on what needs to be achieved. Whether I'm in there or not that timeline needs to be adhered to. The company is motoring along fine. Stepping aside is not something that I think will fundamentally affect the opportunity for the company. What happens if you win? There are mechanisms where I can put the shares into a trust. I would be very proud that it was a company that I started and be very keen to still follow the journey, just not as CEO. Nutriband as a whole is going to do a lot of will help a lot of people who are dealing with addiction and people who are dealing with pain. *An earlier version of this article stated a higher target figure for contract manufacturing, which has since been revised by the company.


Irish Times
11 hours ago
- Irish Times
The Irish Times view on Budget 2026: put the focus on what is important
Over the next couple of weeks, as the Autumn political season starts to kick in, debate on October's budget will get underway in earnest. As ever, there will be a cacophony of demands from interest groups and lobbyists, looking for more spending or lower taxes for their particular cause. The job of the Government, of course, is to look through the noise to what is important. Despite the generous amount of €9.4 billion set aside for budget measures, this will not be easy. Money will be quickly eaten up through spending pressures in providing State services. Plans to hike vital investment expenditure need to be allowed for. And the demands on the table already would take up the €1.5 billion set aside for tax reductions a few times over. Yet while the choices will be sharp in some areas, context is needed. This is not shaping up to be a 'tough' budget. The promised package is still nearly three times the size of the last pre-Covid budget in 2019. The first job of the Government, indeed, is to start returning annual budgets to more sustainable levels, reducing them from the huge spending rises required during Covid-19 and to tackle the cost-of-living crisis. Claims that households are still squeezed need to be met in two ways. One is by appropriate increases in welfare and other support packages. The other is by continuing to improve the provision of services in areas such as health, education and childcare. These are much more effective in the longer-term than another round of universal cash supports. But by engaging in a blatant pre-election manoeuvre last year to repeat these 'once-off' supports again, Ministers have created a rod for their own back this time around. READ MORE Statements from Ministers that there would be no cost-of-living package this time appear to have become more equivocal in recent weeks. But giving a lot of money out again through these payments to all households is an inefficient use of State cash. If the Government does not bring this process to an end in the first budget of its new term, then – barring a big squeeze on the State finances – it never will. The plan to increase vital State investment is a key reason why there needs to be some restraint elsewhere. Realistic budgeting for the provision of State services also needs to be restored, ending the annual overruns in areas like health. Relying on corporate tax to keep outperforming as a way to pay for spending coming in ahead of target each year is not a good strategy. The other reason for caution is the uncertainty faced due to the policies of Donald Trump. Despite the trade deal between the EU and US, the economic and political backdrop for Ireland remains risky and unpredictable. Having cash in reserve and pursuing a strategic approach have seldom looked more important.